Advertisement

Topics

Cell Medica boosts manufacturing capacity in cell therapy deal

06:34 EDT 21 Jun 2017 | BioPharmaDive

The U.K. cell therapy company hopes to push forward with development of CGT Catapult's WT1 targeting T-cell receptor technology. 

Original Article: Cell Medica boosts manufacturing capacity in cell therapy deal

NEXT ARTICLE

More From BioPortfolio on "Cell Medica boosts manufacturing capacity in cell therapy deal"

Advertisement
Quick Search
Advertisement
Advertisement